EFTA01492867.pdf

FINANCIAL TRUST COMPANY INC ACCT. For the Period 3/1/12 to 3/31/12 Note P indicates position adjusted for Pending Trade Activity. Unrealized GainLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional information. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc Price Quantity Value Original Cost Gam/Loss Accrued Div. Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 15.98 16,535.000 264,229.30 251,475.52 12,753.78 04033A-10-0 ARIA BIOGEN IDEC INC 126.00 2,095 000 263,970.00 250,454.95 13,515.05 09062X-10-3 BIIB DB DONT BUFF EQ MS 08/07/12 91.64 1,000.000 000 916,400.00 1,000,000.00 (83,600.00) 25% CONTIN BARRIER- 1 3%CPN 30% CAP INITIAL LEVEL-07,15,11 MS 21 09 2515A1-A7-6 P DOLLAR GENERAL CORP 46.20 MOO 256677-10-5 DG P DUNIUN BRANDS GROUP INC 30.06 0.00 1.99% 265504-10-0 DNKN HSBC MARKET PLUS SPX 06117/13 102.72 5,000,000.000 5,138000.00 5,000,000.00 138.000.00 72% KO BARRIER- 096CPN ,UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 4042K1-X0-1 JP Morgan Account Page 5 of 32 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan JPM-SDNY-00015686 Chase CONFIDENTIAL SDNY_GM_00284884 EFTA01492867